Literature DB >> 7935660

Chronic idiopathic thrombocytopenic purpura.

J N George1, M A el-Harake, G E Raskob.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7935660     DOI： 10.1056/NEJM199411033311807

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  32 in total

1.  Successful treatment of immune thrombocytopenic purpura (ITP) with splenectomy.

Authors:  P Ortega Deballon; M T Alonso García; M Moreno Azcoita
Journal:  World J Surg       Date:  2001-02       Impact factor: 3.352

2.  Autoantigenic epitopes on platelet glycoproteins.

Authors:  Yoshiaki Tomiyama; Satoru Kosugi
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

3.  Surgical treatment of a superior sulcus tumor in a patient with idiopathic thrombocytopenic purpura: report of a case.

Authors:  Takahiro Nakajima; Akira Iyoda; Toshihiko Iizasa; Yukio Saitoh; Kenzo Hiroshima; Takehiko Fujisawa
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

Authors:  Ingrid Pabinger; Günther Gastl; Michael Steurer; Siegfried Sormann; Michael Fillitz; Josef Friedl; Dietmar Geissler; Klaus Geissler; Richard Greil; Paul Knöbl; Sibylle Kozek-Langenecker; Peter Krippl; Paul Kyrle; Alois Lang; Werner Linkesch; Heinz Ludwig; Markus Müller; Simon Panzer; Elisabeth Pittermann; Josef Thaler; Ansgar Weltermann
Journal:  Wien Klin Wochenschr       Date:  2012-03-03       Impact factor: 1.704

5.  Low expression of FCGRIIB in macrophages of immune thrombocytopenia-affected individuals.

Authors:  Zhong Wu; Jin Zhou; Pankaj Prsoon; Xiaoxia Wei; Xiaojing Liu; Bing Peng
Journal:  Int J Hematol       Date:  2012-10-10       Impact factor: 2.490

6.  Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates.

Authors:  Erik I Tucker; Ulla M Marzec; Michelle A Berny; Sawan Hurst; Stuart Bunting; Owen J T McCarty; András Gruber; Stephen R Hanson
Journal:  Sci Transl Med       Date:  2010-06-23       Impact factor: 17.956

Review 7.  Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients.

Authors:  N Katkhouda; M B Hurwitz; R T Rivera; M Chandra; D J Waldrep; J Gugenheim; J Mouiel
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

Review 8.  Rituximab in treatment-resistant autoimmune blistering skin disorders.

Authors:  Enno Schmidt; Eva-Bettina Bröcker; Matthias Goebeler
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

9.  Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia.

Authors:  Mingjun Wang; Mengni Zhang; Jin Zhou; Zhong Wu; Ke Zeng; Bing Peng; Ting Niu
Journal:  Int J Hematol       Date:  2013-04-17       Impact factor: 2.490

10.  Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group.

Authors:  Kana Sakamoto; Hideki Nakasone; Shigeharu Tsurumi; Ko Sasaki; Kinuko Mitani; Michiko Kida; Akira Hangaishi; Kensuke Usuki; Ayako Kobayashi; Ken Sato; Mariko Karasawa-Yamaguchi; Koji Izutsu; Yasushi Okoshi; Shigeru Chiba; Yoshinobu Kanda
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.